TrialJournal of gastroenterology2017
Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection.
Joji Toyota et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled ittrialcites it